Ruike Gao

TL;DR: In this paper, the authors summarized the latest evidence of TCM in COVID-19 and concluded that TCM treatment plus routine treatment may not promote the negativity of the SARS-CoV-2 nucleic acid test compared to routine treatment alone.

TL;DR: KLT plus first-line platinum-based chemotherapy, except when chemotherapy regimens were TP, increased efficacy and quality of life in patients with advanced NSCLC and is unsure whether this combination offers a low risk of adverse reactions.

TL;DR: Wang et al. as mentioned in this paper evaluated the reporting quality, methodological quality, risk of bias, and evidence quality of systemic reviews of Kanglaite injection adjuvant therapy for non-small-cell lung cancer (NSCLC).

TL;DR: Wang et al. as discussed by the authors evaluated the efficacy and safety of intra-pleural infusion with Kanglaite injection in the treatment of malignant pleural effusion (MPE) in 20 randomized controlled trials.

TL;DR: Wang et al. as mentioned in this paper evaluated the efficacy and safety of TCM therapies combined with HIPEC in the treatment of peritoneal metastasis of GC by effective rate, Karnofsky Performance Status, Carcinoemybryonic Angtigen remission rate, and incidence of adverse reactions etc.